Date: 2015-02-13
Type of information: Collaboration agreement
Compound:
Company: Medtronic (USA - MN) The American Heart Association - American Stroke Association (USA)
Therapeutic area: Cardiovascular diseases
Type agreement: collaboration
Action mechanism:
Disease: stroke
Details: * On February 13, 2015, the American Heart Association/American Stroke Association (AHA/ASA) and Medtronic announced a collaboration to reduce the rate of recurrent strokes in the U.S. The two organizations will work together over several years to educate, raise awareness and support effective management of patients who have strokes. The initiative, announced at the American Stroke Association\'s annual International Stroke Conference in Nashville, Tennessee, will focus on reducing strokes of unknown cause, called \"cryptogenic stroke.\" Recent studies have shown that many stroke patients have a common heart condition called atrial fibrillation (or AF), when the heart beats irregularly or rapidly. Patients with AF are five times more likely to have strokes,ii but their condition often goes undiagnosed because their AF episodes occur only sporadically and may not have any symptoms. Studies have shown that continuous, long-term cardiac monitoring of cryptogenic stroke patients helps physicians detect and diagnose AF and provide treatment to prevent a recurrent stroke. The new collaboration will support the American Heart Association/American Stroke Association\'s goal to reduce death from stroke by 20 percent by 2020.
Financial terms:
Latest news:
